With plans to commercialize its pancreatic cancer test in the U.S. by late 2025, Immunovia seeks financial leadership with diagnostics expertise and global capital market experience....
Following constructive discussions with the FDA, Co-Dx shifts focus to an improved test submission, incorporating platform advancements and optimizing long-term performance....
With all female patients in its groundbreaking clinical feasibility study reaching six-month primary endpoints, UroMems' UroActive System marks a transformative step in treating stress urinary incontinence. The AI-powered smart implant, designed to enhance patient quality of life, is now paving the way for expanded adoption in the U.S. and Europe. ...
3Shape is celebrating 25 years of innovation by introducing a paradigm shift in CAD workflows for dental labs with the upcoming release of 3Shape Dental System 2024. This new software update will include a free AI-driven crown design application along with several workflow enhancements to significantly improve efficiency and digitization for dental labs. As the first employee hired at 3Shape 25 years ago, Rune Fisker, Senior Vice President of Product Strategy, reflects on the remarkable evolu...
With its innovative, technology-driven model, Encore Wound Care extends its footprint to Tennessee, enhancing clinical outcomes, optimizing facility operations, and treating over 10,000 wounds per week across its growing service regions....
With groundbreaking ultrasound-based solutions for brain cancer and drug-resistant epilepsy, NaviFUS expands its global impact through strategic industry collaborations, clinical breakthroughs, and partnerships with leading healthcare innovators....
LiS Academy, an independent academic forum led by top oncologists, aims to enhance awareness and adoption of liquid biopsies for personalized cancer care in India....
Designed for emergency settings, the new tray features the Ultraplex® 360 Needle with advanced echogenic technology, enabling precise regional anesthesia as a safer alternative to opioids. ...
Largest Randomized AI Mammography Study Shows 29% Higher Cancer Detection with 44% Less Screen-Reading Burden...
By compressing decades of medical discoveries into a single day, NeuralCure AI’s cutting-edge platform accelerates treatment breakthroughs for complex diseases. The company launches a new funding round to expand AI-driven diagnostics and personalized medicine on a global scale....
